Literature DB >> 24246673

In vitro dissolution of calcium oxalate stones with ethylenediaminetetraacetic acid and snake venom thrombin-like enzyme.

Xiang-Jun Zhou1, Jie Zhang, Ci Zhang, Chang-Geng Xu.   

Abstract

OBJECTIVE: The aim of this study was to determine the feasibility of using snake venom thrombin-like enzyme (SVTLE) and/or ethylenediaminetetraacetic acid (EDTA) to dissolve calcium oxalate stones in vitro.
METHODS: Seven calcium oxalate stones were incubated with various chemolytic agents [EDTA, Tris-HCl/EDTA (TE) buffer or SVTLE diluted in TE buffer]. The pH, calcium concentration, stone weight and stone surface integrity were recorded, as well as related pathological changes to bladder mucosae.
RESULTS: Compared to all other solutions, those containing SVTLE and buffered EDTA had higher concentrations of mobilized calcium and caused significantly more stone weight loss, stone fragility and gaps in the calcium crystals. Also, there were no adverse pathological effects on rabbit bladder mucosae from any of the solutions.
CONCLUSIONS: The data indicate that buffered EDTA and SVTLE can be used to dissolve calcium oxalate stones and, at the concentrations used here, do not damage tissue. 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24246673     DOI: 10.1159/000353096

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Do organic substances act as a degradable binding matrix in calcium oxalate kidney stones?

Authors:  Adi Adelman; Yaniv Shilo; Jonathan Modai; Dan Leibovici; Ishai Dror; Brian Berkowitz
Journal:  BMC Urol       Date:  2021-03-26       Impact factor: 2.264

2.  Use of tetrasodium EDTA acid for the treatment of intraluminal obstruction of subcutaneous ureteral bypass devices.

Authors:  Valerie Duval; Marilyn Dunn; Catherine Vachon
Journal:  J Feline Med Surg       Date:  2022-06-28       Impact factor: 1.971

3.  Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats.

Authors:  Colin Chik; Allyson C Berent; Chick W Weisse; Marcia Ryder
Journal:  J Vet Intern Med       Date:  2019-08-06       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.